Pfizer and Moderna Bivalent COVID-19 Vaccines Authorized to Use as Booster Doses in Children Ages Five Years and Older
In an October 12, 2022, announcement, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUA) for the use of Bivalent COVID-19 vaccines from Pfizer BioN-Tech for ages five years and older, and Moderna for ages six years and older, as a booster dose